Friday, May 20, 2022 | Last Update : 10:23 AM IST

AstraZeneca

AstraZeneca Covid vaccine's third dose ups antibody response to Omicron: Study

The results were observed among individuals previously vaccinated with either Vaxzevria or an mRNA vaccine

13 Jan 2022 4:11 PM

2 doses of Covid vaccines induce lower antibody levels against Omicron: Oxford study

The researchers noted that these data are important but are only one part of the picture

14 Dec 2021 1:47 PM

AstraZeneca, Sputnik V 'mix & match' vaccine joint trials show no adverse events

Interim analysis of the data demonstrates a high safety profile for the combined use of the vaccines

30 Jul 2021 3:11 PM

France allows visitors with Indian-made AstraZeneca vaccine

Several other EU countries already accept the Indian version, which is notably used in the U.K. and around Africa

17 Jul 2021 6:01 PM

Karan Thapar | Mind the gap: Covishield’s 2nd jab sets off controversy

Paradoxically, three days after India’s May decision, and because of the threat of the Delta variant, the UK reduced the gap to eight weeks

25 Jun 2021 12:40 AM

ADVERTISEMENT

India close to giving indemnity to foreign vaccine makers like Pfizer: Report

The government has already met one of Pfizer's other key demands by dropping a requirement that foreign vaccines undergo local trials

10 Jun 2021 5:57 PM

Chinese hackers target Indian vaccine makers

Chinese hacking group APT10, also known as Stone Panda, identified gaps in the IT infra and supply chain software of Bharat Biotech and SII

02 Mar 2021 8:00 AM

Oxford University COVID-19 vaccine 'encouraging' for older age groups

Older individuals are at disproportionate risk of severe COVID-19 and so any vaccine adopted for use must be effective in older adults

19 Nov 2020 2:38 PM

SII to restart COVID vaccine trials as India tally breaches 50L mark

The trials of the Oxford COVID-19 vaccine candidate were halted world over after one volunteer developed 'unexplained illness'

17 Sep 2020 12:32 PM

Trials will have ups and downs, say scientists

Adverse effects were noted on two human subjects who volunteered for the phase 3 trials of AstraZeneca COVID-19 vaccine

11 Sep 2020 1:15 PM

ADVERTISEMENT

DCGI issues notice to Serum Institute over AstraZeneca's trial suspension

DGCI sought an immediate reply, saying else "it shall be construed that you have no explanation to offer and action will be taken"

10 Sep 2020 10:29 AM

AstraZeneca pauses COVID-19 vaccine trial after unexplained illness

AstraZeneca is one of nine companies currently in late-stage Phase 3 trials for their COVID-19 vaccine candidates

09 Sep 2020 8:51 AM

Two volunteers who were given Oxford vaccine are fine

The vaccine trials are being conducted by the Serum Institute of India in Pune

27 Aug 2020 12:29 PM

Coronavirus vaccine should be mandatory in Australia: PM

Anticipating a backlash from vocal anti-vaccine activists, Morrison said the stakes were too high to allow the disease to continue unchecked

20 Aug 2020 1:22 PM

India's Wockhardt to supply COVID-19 vaccines to UK

UK government reserved one fill-and-finish production line at Wockhardt subsidiary in Wrexham, Wales for exclusive use for next 18 months

03 Aug 2020 4:27 PM

ADVERTISEMENT

Five key takeaways from Monday's data on experimental coronavirus vaccines

Oxford University and AstraZeneca announced their vaccine's success in inducing immune responses in volunteers without causing side effects

21 Jul 2020 1:37 PM

Russia to mass-produce its experimental COVID-19 vaccine

The first human trial of the vaccine, a month-long test on 38 people, ended this week, and Phase III trial is set to begin in August

16 Jul 2020 8:26 PM

Race for virus vaccine could leave some countries behind

Rich countries are rushing to place advance orders for the inevitably limited supply to guarantee their citizens get immunized first

18 Jun 2020 12:01 PM

AstraZeneca approaches Gilead about potential merger

Gilead, AstraZeneca and several other drugmakers are racing to develop vaccines for COVID-19

07 Jun 2020 4:06 PM

AstraZeneca to distribute Sun Pharma cancer medicines in China

Shares of Sun Pharma rose as much as 5.4 per cent to a nine-week high after the announcement.

06 Nov 2019 12:49 PM

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT